SUMMARY

The Food and Drug Administration (FDA) and Medical Device Innovation Consortium (MDIC) is announcing a co-sponsored public meeting “FDA/MDIC Symposium on Computational Modeling and Simulation.” The purpose of the meeting is to explore the latest innovations in computational modeling and simulation for developing in silico decision-making evidence. Co-organized by FDA members of the MDIC Computational Modeling and Simulation Steering Committee and medical device industry leaders, this event is designed to spearhead innovation and foster collaboration in the realm of computational modeling and simulation for the advancement of evidence in the medical device industry.

BACKGROUND

What to Expect at FDA/MDIC Symposium on Computational Modeling and Simulation

• Cutting-edge Training: Dive into the intricacies of model credibility assessment and the art of effectively presenting computational evidence in regulatory submissions to the FDA. End of
  Translation Expert-led sessions will provide insights into best practices and strategies to ensure models meet the highest standards of credibility and reliability.
• Explore Cutting-edge Applications: Explore the forefront of computational evidence application in both clinical and non-clinical domains, where industry leaders will unveil the latest innovations and breakthroughs shaping the future of medical device development and compliance.
• Interactive Discussions: Engage in dynamic discussions that foster an exchange of groundbreaking information and ideas. Discover how industry can collectively advance computational modeling and simulation toward attaining high quality evidence, setting the stage for transformative advancements in bringing innovative devices to market.
• Real-World Case Studies: Gain valuable insights from in-depth case studies showcasing successful approaches to assessing model credibility. Learn from practical examples that demonstrate how to navigate challenges and leverage opportunities in the computational evidence landscape.
• Insights for Decision Making: Acquire valuable perspectives on the pivotal role of modeling and simulation in the decision-making process. Uncover the potential of computational modeling and simulation in shaping the future of assessments and decision-making protocols.
• Exhibition and Poster Sessions: Immerse yourself in a rich tapestry of innovation at the poster exhibits. Explore the latest tools, technologies, and advancements in computational modeling and simulation, showcasing the cutting­ edge contributions of industry trailblazers and thought leaders.

HYPERLINKS TO THE WEBPAGE

• Date, Time, and Location:
• Agenda
• Registration
• Contact

DATE, TIME, and LOCATION

This meeting will be held on April 16-17, 2024, beginning at 8:30 AM ET daily, at the following location: College Park Marriott Hotel and Conference Center, 3501 University Boulevard East, Hyattsville, MD 20783.

WEBCAST

The co-sponsored meeting will not be webcast.

AGENDA

The meeting details, including the most current agenda, are available at https://mdic.org/event/mdic-symposium-on-computational-modeling-and-simulation/.

REGISTRATION

If you wish to attend this co-sponsored meeting, you must register. For registration, please visit: https://whova.com/portal/registration/mdica_202404/.

CONTACT

For questions regarding meeting content, please contact:

Brent Craven
Office of Science and Engineering Laboratories
Center for Devices and Radiological Health
U.S. Food and Drug Administration
10903 New Hampshire Ave Silver Spring, MD 20903
Tel: 301-796-2509
Brent.Craven@fda.hhs.gov